Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03220750
Other study ID # 2016YFC1000401
Secondary ID
Status Recruiting
Phase N/A
First received July 12, 2017
Last updated July 13, 2017
Start date March 28, 2017
Est. completion date December 31, 2020

Study information

Verified date July 2017
Source Peking University
Contact Jian-meng Liu, PhD
Phone 86-10-82801136
Email liujm@pku.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The University Hospital Advanced Age Pregnant (UNIHOPE) Cohort is the major part of the National Key Research and Development Program on Reproductive Health & Major Birth Defects Control and Prevention Project, which is funded by the Ministry of Science and Technology of China. The Project is led by Prof. Zhao Yangyu, from the Department of Gynecology & Obstetrics, Peking University Third Hospital, and the UNIHOPE cohort is led by Prof. Jian-meng Liu, the Co-PI of the Project.


Description:

The UNIHOPE Cohort is set up to provide comprehensive evidence for the prevention and treatment of gestational complications in pregnant women with advanced maternal age, and therefore, to meet the growing clinical challenges of increasing pregnant women with advanced age in the two-child era. The UNIHOPE Cohort is planning to recruit 22,000 pregnant women aged ≥35 years from 9 large obstetrical center of major University-affiliated Hospitals across China, between July 2016 and December 2020. All women will be enrolled prior to 14 wks of gestation, followed up at 24-28 wks, 32-34 wks of gestation, delivery, and 42 days postpartum. Data including demographics, medical history, reproductive history, prenatal health care, gestational complications, and pregnancy and birth outcomes will be collected via electronic data capture system. Venous blood of the pregnant women will be collected at enrollment and each follow-up visit during pregnancy, and placental tissue, cord blood and hair of the newborn will also be collected.


Recruitment information / eligibility

Status Recruiting
Enrollment 22000
Est. completion date December 31, 2020
Est. primary completion date December 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 35 Years to 60 Years
Eligibility Inclusion Criteria:

- Female aged = 35 years

- Less than 14 gestational weeks

- Planning to receive prenatal healthcare and delivery service at the study hospital

Exclusion Criteria:

- Inability to provide informed consent

- Women with mental disorders

Study Design


Locations

Country Name City State
China Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing
China Peking University First Hospital Beijing
China Peking University Third Hospital Beijing
China West China Second University Hospital Chengdu
China The First Affiliated Hospital of Chongqing Medical University Chongqing
China The Third Affiliated Hospital of Guangzhou Medical University Guangzhou
China Obstetrics and Gynecology Hospital of Fudan University Shanghai
China Shengjing Hospital of China Medical University Shenyang
China Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan

Sponsors (11)

Lead Sponsor Collaborator
Peking University Beijing Obstetrics and Gynecology Hospital, Capital Medical University, First Affiliated Hospital of Chongqing Medical University, Obstetrics & Gynecology Hospital of Fudan University, Peking University First Hospital, Peking University Third Hospital, Shengjing Hospital, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, The Third Affiliated Hospital of Guangzhou Medical University, Tongji Hospital, West China Second University Hospital

Country where clinical trial is conducted

China, 

References & Publications (10)

Carolan M. Maternal age =45 years and maternal and perinatal outcomes: a review of the evidence. Midwifery. 2013 May;29(5):479-89. doi: 10.1016/j.midw.2012.04.001. Epub 2012 Nov 16. Review. — View Citation

Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, Saade GR, Eddleman KA, Klugman S, Dugoff L, Timor-Tritsch IE, Craigo SD, Carr SR, Wolfe HM, Bianchi DW, D'Alton M; FASTER Consortium. Impact of maternal age on obstetric outcome. Obstet Gynecol. 2005 May;105(5 Pt 1):983-90. — View Citation

Jolly M, Sebire N, Harris J, Robinson S, Regan L. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod. 2000 Nov;15(11):2433-7. — View Citation

Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2013 Dec;42(6):634-43. doi: 10.1002/uog.12494. — View Citation

Laopaiboon M, Lumbiganon P, Intarut N, Mori R, Ganchimeg T, Vogel JP, Souza JP, Gülmezoglu AM; WHO Multicountry Survey on Maternal Newborn Health Research Network. Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG. 2014 Mar;121 Suppl 1:49-56. doi: 10.1111/1471-0528.12659. — View Citation

Lisonkova S, Janssen PA, Sheps SB, Lee SK, Dahlgren L. The effect of maternal age on adverse birth outcomes: does parity matter? J Obstet Gynaecol Can. 2010 Jun;32(6):541-8. — View Citation

Lisonkova S, Potts J, Muraca GM, Razaz N, Sabr Y, Chan WS, Kramer MS. Maternal age and severe maternal morbidity: A population-based retrospective cohort study. PLoS Med. 2017 May 30;14(5):e1002307. doi: 10.1371/journal.pmed.1002307. eCollection 2017 May. — View Citation

Ngowa JD, Ngassam AN, Dohbit JS, Nzedjom C, Kasia JM. Pregnancy outcome at advanced maternal age in a group of African women in two teaching Hospitals in Yaounde, Cameroon. Pan Afr Med J. 2013 Apr 7;14:134. doi: 10.11604/pamj.2013.14.134.2315. Print 2013. — View Citation

Niessen K, Werner-Bierwisch T, Metzing S, Sayn-Wittgenstein FZ. [Motherhood at the Age of 35 and Over: The Risk of Advanced Maternal Age as Perceived by Women - a Literature Study]. Z Geburtshilfe Neonatol. 2017 Jun;221(3):111-121. doi: 10.1055/s-0043-104864. Epub 2017 Jun 30. German. — View Citation

Taghizadeh Z, Cheraghi MA, Kazemnejad A, Pooralajal J, Aghababaei S. Difference in Perception of Pregnancy Risk in Two Maternal Age Groups. J Clin Diagn Res. 2017 May;11(5):QC09-QC12. doi: 10.7860/JCDR/2017/23661.9915. Epub 2017 May 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of major gestational complications and adverse pregnancy outcomes in pregnant women with the advanced age, for a singleton or twin and higher order multiple gestation Gestational diabetes mellitus, hypertensive disease of pregnancy, uterine scar pregnancy, placenta previa, preterm delivery, postpartum hemorrhage, low birth weight, spontaneous abortion, stillbirth, perinatal death At enrollment, 24-28 weeks, 32-34 weeks of gestation, delivery, and 42 days postpartum
Secondary Maternal death Deaths during pregnancy or less than 42 days after termination of pregnancy. At 24-28 weeks, 32-34 weeks of gestation, delivery, and 42 days postpartum
Secondary The rate of cesarean delivery Cesarean rate is defined as the number of cesarean delivery divided by the number of live births. At delivery
Secondary Gestational duration The number of weeks from the first day of the woman's last recorded menstrual period to the day of delivery deaths occurring within 28 days. At enrollment, delivery
Secondary Birth weight Every newborn's weight will be measured twice, but if the difference between the two measurement results is more than 0.1 kg, it will be measured for the third time, Low birth weight was defined as birth weight <2500 g. At delivery
Secondary Birth length Every newborn's length will be measured twice, but if the difference between the two measurement results is more than 0.1 kg, it will be measured for the third time. At delivery
See also
  Status Clinical Trial Phase
Completed NCT02627482 - Ambulatory Fetal Heart Rate Monitoring in Small Babies N/A
Active, not recruiting NCT03904979 - Therapeutic Writing to Reduce Stress N/A
Completed NCT02749851 - Placenta Imaging Project
Completed NCT03772080 - Prematurity Education in High Risk Pregnancies N/A
Recruiting NCT06151613 - Continuous Non-invasive Electrophysiological Monitoring in High Risk Pregnancies N/A
Enrolling by invitation NCT05763069 - HOME: Home Monitoring of High-risk Pregnancies
Completed NCT01708746 - Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views N/A
Not yet recruiting NCT04173559 - Sleep and Tracking Effects in Pregnancy Study N/A
Recruiting NCT03152058 - IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy Phase 2
Not yet recruiting NCT06320054 - Preventing Obstetric Complications With Dietary Intervention N/A
Not yet recruiting NCT04855513 - Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial N/A
Completed NCT03082664 - Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients N/A
Recruiting NCT06279559 - Music Therapy and High-risk Pregnancy N/A
Not yet recruiting NCT05479357 - Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage N/A
Recruiting NCT04203082 - Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries N/A
Completed NCT02379351 - Use Of An In-Home Non-Stress Test Device For Remote Fetal Monitoring N/A
Recruiting NCT04783597 - Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies
Recruiting NCT06130150 - Sexual Function in High-risk Pregnant Women
Recruiting NCT03775954 - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Suspended NCT02838030 - Efficacy of Aspirin and L-arginine in High Risk Preeclamptic Phase 2